Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
103 Cards in this Set
- Front
- Back
Anthrax
Contraindications: |
Severe allergic reaction after previous dose of BioThrax
|
|
Anthrax
Storage: |
2c - 8c
DO NOT FREEAE Do not use BioThrax after exp. printed date |
|
Hep A Vaccine
Indications: |
> 19 yrs
Mandatory for AD Geographics of endemic areas Ppl engaging in high-risk sexual activity |
|
Hep A Vaccine
Dosage: |
1.0mL IM deltoid
|
|
Hep A Vaccine
Primary series: |
Single dose given followed with a booster 6-12mths for Harvix or 6-18 mths later for Vaqta
|
|
Hep A Vaccine
Contraindications: |
Hypersensitivity to any component of the vaccine
|
|
Hep A Vaccine
Storage: |
35- 46 F
|
|
Hep B Vaccine
Indications: |
Infant born to HBsAg + mom
Children born after 21NOV1991 Adolescents HCP High risk areas Embalmers, AD, bld bank workers |
|
Hep B Vaccine
Dosage: |
1.0mL IM deltoid( >19yrs)
DO NOT INJECT IV or ID |
|
Hep B Vaccine
Primary series: |
Three (3) dose regimen.
First at elected date, second one (1) mth later, and thrid six (6) mths after first |
|
Hep B Vaccine
Contraindications: |
Hypersensitivity to yeast
Any component of vaccine |
|
Human Papillomavirus (Gardasil)
Indications: |
Females 9-26 yrs
Prevention of HPV types 6,11,16, & 18 |
|
Human Papillomavirus (Gardasil)
Dosage: |
0.5mL IM
|
|
Human Papillomavirus (Gardasil)
Primamry series: |
First dose at elected date, second two (2) mths, third six (6) mths after first dose
|
|
Human Papillomavirus (Gardasil)
Contraindications: |
Hypersensitivity to active/any component of vaccine
|
|
Human Papillomavirus (Gardasil)
Storage: |
35-46 F
Do not freeze Protect from light |
|
Influenza (flu) injectable
Indications: |
Mandatory for all AD
HCP >= 65yrs Chronic disorders of pulmonary/cardiovascular system Women in 2nd or 3rd trimester of pregnancy during season |
|
Influenza (flu) injectable
Dosage: |
Shaken well, 0.5mL IM
|
|
Influenza (flu) injectable
Priamary series: |
Annually
|
|
Influenza (flu) injectable
Contraindications: |
Hypersensitivity to eggs or egg product
Sensitivity to thimerosal Do NOT administer to ppl witha history of GBS |
|
Influenza (flu) injectable
Storage: |
35-46F
|
|
Influenza (flu) intranasal
Indications: |
Mandatory of all AD
HCP Person 2-49yrs Healthy children & adults |
|
Influenza (flu) intranasal
Dosage: |
0.20mL
|
|
Influenza (flu) intranasal
Contraindications: |
Do NOT administer parenterally
Hypersensitivity to Flumist, eggs or egg product 2-17yrs do NOT give Pts witha history of GBS |
|
Influenza (flu) intranasal
Storage: |
35-46F
Discard froozen vaccine |
|
Japanese Encephalitis Vaccine
Indications: |
Travelers spending mth or longer in endemic areas
Lab workers |
|
Japanese Encephalitis Vaccine
Dosage: |
1.0mL for pts >3 and older
0.50mL for pts 35mths-1yrs old SQ |
|
Japanese Encephalitis Vaccine
Primary Series: |
Three (3) doses given at 0, 7 and 30days for optimal effectiveness. Give third dose at least 10 days before travel of endemic areas.
|
|
Japanese Encephalitis Vaccine
Contraindications: |
Allergic reaction to vaccine/components
Ppl with multi allergies Pregnancy |
|
Japanese Encephalitis Vaccine
Storage: |
35-46F
Protect from sunlight Reconstitute with sterile water |
|
Measles, Mumps, Rubella (M-M-RII)
Indications: |
>18yrs
College students HCP Women of childbearing age who do not have evidence of immunity |
|
Measles, Mumps, Rubella (M-M-RII)
Dosage: |
0.5mL SQ
|
|
Measles, Mumps, Rubella (M-M-RII)
Primary Series: |
One dose for adults is all that is needed.
Second dose "if recommended" four (4) wks between the 1st and 2nd shot |
|
Measles, Mumps, Rubella (M-M-RII)
Contraindications: |
Hypersensitivity to vaccine or gelatin, or neomycin
Pregnancy |
|
Measles, Mumps, Rubella (M-M-RII)
Storage: |
35-46F
Store diluent at room temp DO NO SHAKE |
|
Meningococcal Polysaccharide Vaccine Group A, C, Y AND W-135 COMBO (Menomune-A/C/Y/W- 135)
Indications: |
Functional asplenia
LAB or industrial exposure to N. meningitides aerosols Traveling to endemic areas College students |
|
Meningococcal Polysaccharide Vaccine Group A, C, Y AND W-135 COMBO (Menomune-A/C/Y/W- 135)
Dosage: |
0.5mL SQ
|
|
Meningococcal Polysaccharide Vaccine Group A, C, Y AND W-135 COMBO (Menomune-A/C/Y/W- 135)
Priamry Series: |
Single dose
|
|
Meningococcal Polysaccharide Vaccine Group A, C, Y AND W-135 COMBO (Menomune-A/C/Y/W- 135)
Booster dose: |
Only given to ind. deploying to endemic areas who have NOT been vaccinated with last 3-5yrs
|
|
Meningococcal Polysaccharide Vaccine Group A, C, Y AND W-135 COMBO (Menomune-A/C/Y/W- 135)
Contraindications: |
Allergic reaction to thimerosal
Pregnancy Acute illness |
|
Meningococcal Polysaccharide Vaccine Group A, C, Y AND W-135 COMBO (Menomune-A/C/Y/W- 135)
Storage: |
35-46F
Discard multi dose within 35days after reconstitution Single dose should be used within 30mins after reconstitution Shake well |
|
Meningococcal (Group A, C, Y AND W-135) Polysaccharide Diptheria Toxiod Conjugate Vaccine Menactra
Indications: |
2- 55yrs
Endemic area College students |
|
Meningococcal (Group A, C, Y AND W-135) Polysaccharide Diptheria Toxiod Conjugate Vaccine Menactra
Dosage: |
0.5mL IM
|
|
Meningococcal (Group A, C, Y AND W-135) Polysaccharide Diptheria Toxiod Conjugate Vaccine Menactra
Primary Series: |
Single dose
|
|
Meningococcal (Group A, C, Y AND W-135) Polysaccharide Diptheria Toxiod Conjugate Vaccine Menactra
Contraindications: |
Allergic history to thimerosal
Pregnancy Acute illness |
|
Meningococcal (Group A, C, Y AND W-135) Polysaccharide Diptheria Toxiod Conjugate Vaccine Menactra
Storage: |
35-46F
Do NOT freeze Protect from light |
|
Inactive Polio Vaccine (IPV, e-IPV, ep-IPV)
Indications: |
Poliomyelitis endemic areas
HCP LAB handling poliovirus Mandatory for AD |
|
Inactive Polio Vaccine (IPV, e-IPV, ep-IPV)
Dosage: |
0.5mL SQ/IM (IPV)
Shake well |
|
Inactive Polio Vaccine (IPV, e-IPV, ep-IPV)
Primary Series: |
Two (2) doses 4 - 8 wks apart
Folowed by a third dose given 6-12 after 2nd dose 0, 30 days & 6-12 mths |
|
Inactive Polio Vaccine (IPV, e-IPV, ep-IPV)
Booster dose: |
International travel to high-risk areas
|
|
Inactive Polio Vaccine (IPV, e-IPV, ep-IPV)
Contraindications: |
Hypersensitivity to vaccine or component; 2-phenoxyethonal, formaldehyde, meomycin, streptomycin, and polymyxin
Pregnancy |
|
Inactive Polio Vaccine (IPV, e-IPV, ep-IPV)
Storage: |
35-46F
Discard frozen vaccine |
|
Pneumococcal Vaccine (PPV 23)
Indications: |
Immunocompetent persons >50yrs
>2yrs with chronic cardiovascular/pulmonary disease, & diabetes mellitus 1 >2yrs with alcoholism, liver disease, or CSF leaks |
|
Pneumococcal Vaccine (PPV 23)
Dosage: |
0.5mL; SQ/IM
Single dose |
|
Pneumococcal Vaccine (PPV 23)
Booster: |
High-risk pts. after 5yrs when previous dose was given, must have PCM order
|
|
Pneumococcal Vaccine (PPV 23)
Contraindications: |
History neurological s/s after adminsitration
Anaphylaxsis to vaccine/component Pregnancy |
|
Pneumococcal Vaccine (PPV 23)
Storage: |
35-46F
Discard frozen Shake well |
|
Rabbies Vaccine
Imovax or RabVert Indications: |
High-risk exposure to rabies
Veterinarians Certain lab workers Animal handlers Endemic areas |
|
Rabbies Vaccine
Imovax or RabVert Dosage: |
1.0mL IM deltoid area
|
|
Rabies Vaccine
Imovax or RabVert Primary Series: Pre-exposure |
Three (3) dose on days 0, 7 and 21-28 days
|
|
Rabies Vaccine
Imovax or RabVert Primary Series: Post-exposure |
Rabies immune globin STAT five (5) doses of rabies vaccine on 0,3,7,14 and 28 days
|
|
Rabies Vaccine
Imovax or RabVert Booster: |
Can be every five (5) yrs based on antibodies titers and risk
|
|
Rabies Vaccine
Imovax or RabVert Contraindications: |
History to vaccine/components
|
|
Rabies Vaccine
Imovax or RabVert Storage: |
35-46F
Discard frozen Swirl vaccine DO NOT SHAKE |
|
Shingles ZOSTAVAX
Indications: |
Prevention of herpes zoster(shingles) >60yrs
|
|
Shingles ZOSTAVAX
Contraindications: |
Anaphylactic reaction to gelatin, neomycin, and other components of vaccine
Active untreated TB Pregnancy Immunocompromised |
|
Shingles ZOSTAVAX
Storage: |
FROZEN at avg temp of -15c
|
|
Smallpox (ACAM2000)
Indications: |
Imm. against smallpox as directed by DoD
|
|
Smallpox (ACAM2000)
Primary Vaccination: |
Fifteen (15) percutaneous route, using jabs
|
|
Smallpox (ACAM2000)
Booster: |
Every three (3) yrs for LAB handling variola virus
|
|
Smallpox (ACAM2000)
Contraindications: |
Immunodeficient individuals
Allergic to neomycin, polymyxin B |
|
Smallpox (ACAM2000)
Storage: |
Frozen avg temp -15c to -25c
|
|
Tetanus/Diphtheria (Td) ADULT
Indications: |
>7yrs
Mandatory for AD Occupations susceotable to llacerations/abrasions |
|
Tetanus/Diphtheria (Td) ADULT
Dosage: |
0.5mL, IM; shake well before each dose
|
|
Tetanus/Diphtheria (Td) ADULT
Primary series: |
Two (2) doses given at 4 - 8wk interval, followed by a third 6 - 12mths after 2nd dose.
0, 30days & 6 - 12mths Completed in childhood |
|
Tetanus/Diphtheria (Td) ADULT
Booster: |
10yrs intervals to maintain immunity
|
|
Tetanus/Diphtheria (Td) ADULT
Contraindications: |
Hypersensitivity to any component of vaccine, & thimerosal
Pregnancy |
|
Tetanus/Diphtheria (Td) ADULT
Storage: |
35-46F
Do NOT frezze Doscard if frozen |
|
Tdap (ADACEL)
Indactions: |
Prevention of tetanus, diphtheria, & pertussis
11- 64yrs |
|
Tdap (ADACEL)
Dosage: |
0.5mL IM
Single dose Shake well |
|
Tdap (ADACEL)
Booster: |
If not received within 5yrs
Every ten (10) yrs |
|
Tdap (ADACEL)
Contraindications: |
Hypersensitivity to vaccine/components
|
|
Tdap (ADACEL)
Storage: |
35-46F
Do NOT freeze Discard if frozen |
|
Tdap (BOOSTRIX)
Indications: |
10- 64 yrs
|
|
Tdap (BOOSTRIX)
Dosage: |
0.5mL IM
Shake well One (1) dose for LIFETIME |
|
Tdap (BOOSTRIX)
Contraindications: |
Hypersensitivity to vaccine/components
|
|
Tdap (BOOSTRIX)
Storage: |
35-46F
Do NOT freeze Discard if frozen |
|
Twinrix (Hep A inactivated & Hep B) Recombinant Vaccine
Indications: |
Pts with chronic liver disease
LAB workers 1st responders Workers who come in contact with sewage/feces HCP Military Endemic areas |
|
Twinrix (Hep A inactivated & Hep B) Recombinant Vaccine
Dosage: |
1.0mL
|
|
Twinrix (Hep A inactivated & Hep B) Recombinant Vaccine
Primary series: |
Three (3) doses, gievn at 0days, 1 mth, and 6 mths mark
|
|
Twinrix (Hep A inactivated & Hep B) Recombinant Vaccine
Contraindications: |
Allergic action to previous dose
|
|
Twinrix (Hep A inactivated & Hep B) Recombinant Vaccine
Storage: |
35-46F
Do NOT freeze Discard if frozen |
|
Typhoid Vaccine (Oral) (Ty21a)
Indications: |
Mandatory for AD
Travel to endemic areas |
|
Typhoid Vaccine (Oral) (Ty21a)
Dosage: |
Four (4) capsules orally
Taken every other day, one (1) hour before meals |
|
Typhoid Vaccine (Oral) (Ty21a)
Primary Series: |
Four (4) capsules, every other day. At least one (1) wk before travel
|
|
Typhoid Vaccine (Oral) (Ty21a)
Booster: |
Repeat four (4) capsule every five (5) yrs
|
|
Typhoid Vaccine (Oral) (Ty21a)
Contraindications: |
Hypersenistivity to any component of vaccine
Do NOT take during acute GI illness If taking antibiotics |
|
Typhoid Vaccine (Oral) (Ty21a)
Storage: |
35-46F
Discard if frozen |
|
Typhoid Vaccine (Typhim Vi)
Indications: |
Travel to endemic areas
Intimate exposure Microbiology workers in contact with S.Typhi |
|
Typhoid Vaccine (Typhim Vi)
Dosage: |
Typhoid Vi 0.5mL IM
|
|
Typhoid Vaccine (Typhim Vi)
Primary Series: |
Single dose
|
|
Typhoid Vaccine (Typhim Vi)
Contraindications: |
Allergic reaction to vaccine/components
|
|
Typhoid Vaccine (Typhim Vi)
Storage: |
35-46F
Do not freeze Discard if frozen |